• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study.直接准入转诊的床边丙型肝炎筛查提高中途之家居民的护理衔接:一项试点随机研究。
Singapore Med J. 2022 Feb;63(2):86-92. doi: 10.11622/smedj.2020116. Epub 2020 Jul 30.
2
Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.澳大利亚市中心急诊部门即时检测丙型肝炎病毒和与治疗的衔接
Int J Drug Policy. 2019 Oct;72:84-90. doi: 10.1016/j.drugpo.2019.06.021. Epub 2019 Jul 24.
3
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.干预措施以提高注射毒品者丙型肝炎感染的检测和治疗关联:系统评价和荟萃分析。
Int J Drug Policy. 2023 Jan;111:103917. doi: 10.1016/j.drugpo.2022.103917. Epub 2022 Dec 19.
4
The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study.在针具交换项目中进行即时丙肝检测对注射吸毒者的治疗衔接和治疗参与的影响:澳大利亚试点研究。
J Viral Hepat. 2022 May;29(5):375-384. doi: 10.1111/jvh.13664. Epub 2022 Mar 21.
5
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination.以消除丙型肝炎为目标的基于护理点的丙型肝炎检测和治疗策略:为丙型肝炎防治和成瘾中心就诊者提供服务。
J Viral Hepat. 2022 Mar;29(3):227-230. doi: 10.1111/jvh.13634. Epub 2021 Nov 29.
6
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.一项由同伴协助参与、即时 HCV RNA 检测以及与护理支持联系组成的测试活动干预措施,旨在提高注射毒品人群的丙型肝炎治疗吸收率:ETHOS Engage 研究。
Viruses. 2022 Jul 16;14(7):1555. doi: 10.3390/v14071555.
7
Pilot model of hepatitis C virus micro-elimination in high-risk populations in Hong Kong: Barriers and facilitators.香港高危人群丙型肝炎病毒微消除的试点模型:障碍和促进因素。
Int J Drug Policy. 2024 Oct;132:104568. doi: 10.1016/j.drugpo.2024.104568. Epub 2024 Aug 31.
8
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility.即时检测 HCV RNA 可提高接受医疗监督注射设施服务的注射吸毒人群的 HCV 检测率并能快速开始治疗。
Int J Drug Policy. 2024 Mar;125:104317. doi: 10.1016/j.drugpo.2024.104317. Epub 2024 Jan 28.
9
Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis.即时检测与实验室检测丙型肝炎病毒 RNA 病毒载量对 RNA 检测和治疗的影响,以及周转时间:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Mar;8(3):253-270. doi: 10.1016/S2468-1253(22)00346-6. Epub 2023 Jan 24.
10
Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark.通过丹麦哥本哈根的一个流动诊所,为边缘化人群提供同伴提供的即时检测和与治疗相关的服务,以治疗丙型肝炎病毒感染。
Int J Drug Policy. 2023 Nov;121:104185. doi: 10.1016/j.drugpo.2023.104185. Epub 2023 Sep 27.

引用本文的文献

1
A scoping review on HCV screening strategies: population to screen and the test types.关于丙型肝炎病毒(HCV)筛查策略的范围综述:筛查人群及检测类型
BMC Public Health. 2025 Jul 30;25(1):2589. doi: 10.1186/s12889-025-23809-7.
2
Status of hepatitis B virus and hepatitis C elimination in Singapore: a call for action.新加坡乙肝和丙肝消除现状:行动呼吁
Singapore Med J. 2025 Jul 1;66(7):376-378. doi: 10.4103/singaporemedj.SMJ-2025-142. Epub 2025 Jul 24.
3
Knowledge, Attitude and Factors associated with Self-efficacy in Screening and Treatment of Hepatitis C among Primary Care Doctors in Selangor.雪兰莪基层医疗医生在丙型肝炎筛查和治疗中与自我效能相关的知识、态度及因素
Malays Fam Physician. 2024 Feb 20;19:11. doi: 10.51866/oa.454. eCollection 2024.
4
Efficacy of a comprehensive strategy for the detection and treatment of hepatitis C infection in a population attending addiction centers.在成瘾中心就诊人群中实施丙型肝炎感染检测和治疗综合策略的效果。
Front Public Health. 2023 Feb 2;11:1092960. doi: 10.3389/fpubh.2023.1092960. eCollection 2023.
5
Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs.小城镇同伴支持:为注射毒品者提供去中心化的移动丙型肝炎病毒诊所。
Liver Int. 2022 Jun;42(6):1268-1277. doi: 10.1111/liv.15266. Epub 2022 Apr 12.
6
Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications.由于治疗参与率下降和晚期肝病并发症的持续负担,澳大利亚可能无法实现世界卫生组织丙型肝炎病毒消除目标。
PLoS One. 2021 Sep 16;16(9):e0257369. doi: 10.1371/journal.pone.0257369. eCollection 2021.
7
Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.在监狱中关押人群中消除丙型肝炎:在卫生系统框架内采取行动的挑战和建议。
Lancet Gastroenterol Hepatol. 2021 May;6(5):391-400. doi: 10.1016/S2468-1253(20)30365-4.
8
The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients.无限制获得直接作用抗病毒药物对被监禁丙型肝炎病毒感染患者的影响。
Clin Mol Hepatol. 2021 Jul;27(3):474-485. doi: 10.3350/cmh.2021.0015. Epub 2021 Feb 19.
9
What is required for achieving hepatitis C virus elimination in Singapore? A modeling study.在新加坡实现丙型肝炎病毒消除需要什么?一项建模研究。
J Gastroenterol Hepatol. 2021 Apr;36(4):1110-1117. doi: 10.1111/jgh.15211. Epub 2020 Sep 3.

本文引用的文献

1
Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore.新型非侵入性评分模型预测丙型肝炎消除时代的肝硬化:新加坡药物滥用者的人群研究。
Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):143-148. doi: 10.1016/j.hbpd.2018.12.002. Epub 2018 Dec 6.
2
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study.澳大利亚有望通过快速初始 DAA 治疗获得世卫组织 HCV 消除目标:一项建模研究。
J Viral Hepat. 2019 Jan;26(1):83-92. doi: 10.1111/jvh.13013. Epub 2018 Nov 14.
3
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.在注射毒品人群中消除丙型肝炎:在卫生系统框架内采取行动的挑战和建议。
Liver Int. 2019 Jan;39(1):20-30. doi: 10.1111/liv.13949. Epub 2018 Sep 22.
4
Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance.治疗诱导病毒清除前后口服液和指血样本中 OraQuick 丙型肝炎病毒抗体检测的性能。
J Clin Virol. 2018 May;102:77-83. doi: 10.1016/j.jcv.2018.02.016. Epub 2018 Feb 24.
5
Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia.澳大利亚慢性丙型肝炎直接抗病毒治疗的接受情况。
J Viral Hepat. 2018 Jun;25(6):640-648. doi: 10.1111/jvh.12852. Epub 2018 Feb 19.
6
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况:多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
7
Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model.我们是否准备好治疗患有阿片类物质使用障碍的丙型肝炎病毒感染者:基于专家生成模型对欧洲国家的准备情况进行评估
Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1206-1214. doi: 10.1097/MEG.0000000000000962.
8
The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries.丙型肝炎消除之路:91个国家治愈病例与新感染病例分析
J Virus Erad. 2017 Jul 1;3(3):117-123. doi: 10.1016/S2055-6640(20)30329-0.
9
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.2015 年全球丙型肝炎病毒感染的流行率和基因型分布:一项建模研究。
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16.
10
Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).慢性丙型肝炎:2012 年法国因住院治疗而产生的疾病负担和费用(HEPC-LONE 研究)。
Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):340-348. doi: 10.1016/j.clinre.2015.08.006. Epub 2015 Nov 3.

直接准入转诊的床边丙型肝炎筛查提高中途之家居民的护理衔接:一项试点随机研究。

Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study.

机构信息

Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore.

Department of Gastroenterology, Sengkang General Hospital, Singapore.

出版信息

Singapore Med J. 2022 Feb;63(2):86-92. doi: 10.11622/smedj.2020116. Epub 2020 Jul 30.

DOI:10.11622/smedj.2020116
PMID:32729280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9251228/
Abstract

INTRODUCTION

Linkage to care among individuals with substance misuse remains a barrier to the elimination of the hepatitis C virus (HCV). We aimed to determine whether point-of-care (PoC) education, screening and staging for liver disease with direct access to hospitals would improve linkage to care among this group.

METHODS

All participants were offered PoC education and HCV screening. HCV-positive participants were randomised to standard care (controls) or direct access, which provided a direct pathway to hospitals. Linkage to care was determined by reviewing electronic medical records. Linkage of care cascade was defined as attendance at the specialist clinic, confirmation of viraemia by HCV RNA testing, discussion about HCV treatment and initiation of treatment.

RESULTS

351 halfway house residents were screened. The overall HCV prevalence was 30.5% (n = 107), with 69 residents in the control group and 38 in the direct access group. The direct access group had a significantly higher percentage of cases linked to specialist review for confirmatory RNA testing (63.2% vs. 40.6%, p = 0.025), HCV treatment discussion (p = 0.009) and treatment initiation (p = 0.01) compared to the controls. Overall, only 12.6% (n = 13) had treatment initiation during follow-up. PoC HCV screening with direct access referral had significantly higher linkage to HCV treatment initiation (adjusted odds ratio 9.13, p = 0.005) in multivariate analysis.

CONCLUSION

PoC HCV screening with direct access improves linkage to care and simplifies the HCV care cascade, leading to improved treatment uptake. PoC education, screening, diagnosis and treatment may be an effective strategy to achieving HCV micro-elimination in this population.

摘要

简介

在药物滥用者中,将其与医疗服务联系起来仍然是消除丙型肝炎病毒(HCV)的障碍。我们旨在确定在这一人群中,使用即时护理(PoC)教育、对肝脏疾病进行筛查和分期并直接转至医院是否能提高与医疗服务的联系。

方法

所有参与者都接受了即时护理教育和 HCV 筛查。HCV 阳性参与者被随机分配至标准护理(对照组)或直接接入组,后者提供了一条直接通往医院的途径。通过查阅电子病历来确定与医疗服务的联系情况。将护理联系的级联定义为参加专家诊所、通过 HCV RNA 检测确认病毒血症、讨论 HCV 治疗和开始治疗。

结果

共对 351 名中途之家居民进行了筛查。总体 HCV 流行率为 30.5%(n = 107),对照组有 69 名居民,直接接入组有 38 名。直接接入组有显著更高比例的病例被联系到专家进行确认 RNA 检测(63.2% vs. 40.6%,p = 0.025)、讨论 HCV 治疗(p = 0.009)和开始治疗(p = 0.01),与对照组相比。总体而言,只有 12.6%(n = 13)在随访期间开始了治疗。多变量分析显示,即时护理 HCV 筛查联合直接转介显著提高了 HCV 治疗开始的联系(调整后的优势比 9.13,p = 0.005)。

结论

即时护理 HCV 筛查联合直接转介可提高与医疗服务的联系,并简化 HCV 护理级联,从而提高治疗的接受率。即时护理教育、筛查、诊断和治疗可能是在这一人群中实现 HCV 微消除的有效策略。